Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens?

Losurdo, Giuseppe; Iannone, Andrea; Giorgio, Floriana; Principi, Mariabeatrice; Di Leo, Alfredo; Ierardi, Enzo

Losurdo, Giuseppe; Iannone, Andrea; Giorgio, Floriana; Principi, Mariabeatrice; Di Leo, Alfredo; Ierardi, Enzo.

Afiliación

Losurdo G; Gastroenterology Section, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Iannone A; Gastroenterology Section, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Giorgio F; Gastroenterology Section, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Principi M; Gastroenterology Section, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Di Leo A; Gastroenterology Section, Department of Emergency and Organ Transplantation, University of Bari, Italy.
Ierardi E; Gastroenterology Section, Department of Emergency and Organ Transplantation, University of Bari, Italy.

United European Gastroenterol J ; 4(3): 474-5, 2016 Jun.

Article en En | MEDLINE | ID: mdl-27403315

Palabras clave

Helicobacter pylori; antibiotic resistance; rescue regimens; rifabutin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: United European Gastroenterol J Año: 2016 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google